Group 1 - Kexin Technology plans to repurchase shares worth between 30 million and 50 million yuan, with a maximum repurchase price of 80 yuan per share, for employee stock ownership plans or capital reduction [1] - Jiahua Technology's shareholder plans to reduce holdings by up to 1.5% of the company's total shares, amounting to a maximum of 116,000 shares, between May 28, 2025, and August 25, 2025 [1] - Beiqi Blue Valley's subsidiary reported cumulative sales of 38,041 vehicles this year, representing a year-on-year increase of 192.53% [2] Group 2 - AVIC Finance plans to transfer shares of AVIC Xi'an Aircraft Industry Group and AVIC Onboard Systems, totaling 4.067 billion yuan, to its controlling shareholder [2] - Haide shares' executives plan to increase their holdings by at least 20.73 million yuan within six months [3] - Dabeinong's subsidiary received planting approval for genetically modified soybeans in Brazil, marking significant progress in the South American market [4] Group 3 - Yongan Pharmaceutical's chairman is under investigation, but the company's operations remain normal [4] - Teruid's subsidiary is expected to win a 126 million yuan project from the State Grid, which will enhance the company's brand and industry influence [4][5] - Junxin shares plan to repurchase shares worth between 200 million and 300 million yuan, with a maximum price of 30.57 yuan per share [5] Group 4 - Meinian Health plans to reduce its holdings by up to 3% of the company's total shares, amounting to a maximum of 11.7 million shares, starting from May 27, 2025 [7] - Electric Power Investment is planning a major asset restructuring, leading to a temporary suspension of its stock [9] - Tongda shares are expected to win a 207 million yuan project from the State Grid, which will positively impact future operating performance [10] Group 5 - Xintian Technology's major shareholder plans to reduce holdings by up to 3% of the company's total shares, amounting to a maximum of 580,410 shares [11] - Huizhou Intelligent's controlling shareholder and some executives plan to increase their holdings by between 29.2 million and 58.4 million yuan [12] - Zhongdali De plans to sell a 50% stake in Shanghai Ketaike Transmission System Co., Ltd. for 9.2777 million yuan to optimize its asset structure [14] Group 6 - Jinlitai's stock will be suspended due to the inability to disclose periodic reports within the statutory deadline [15] - Chuhuan Technology's major shareholder plans to reduce holdings by up to 3% of the company's total shares, amounting to a maximum of 239,560 shares [15] - Guilin Sanjin's subsidiary received approval for clinical trials of a new indication for a monoclonal antibody injection [16] Group 7 - Plit plans to sign a strategic supply agreement for sodium-ion batteries, committing to supply at least 1 GWh over four years [17] - Dalian Electric Porcelain's subsidiary is expected to win a project worth approximately 71 million yuan from the State Grid [18]

Group 1 - Major shareholders of *ST WanFang plan to reduce their holdings by up to 9,341,596 shares, accounting for 3% of the company's total share capital from May 27 to August 25, 2025 [1] - Shareholders of Airo Energy intend to reduce their holdings by up to 800,000 shares, 800,000 shares, and 1,600,000 shares, representing 0.50%, 0.50%, and 1% of the company's total share capital respectively during the same period [1] - Anner plans to reduce its holdings by up to 3,186,159 shares, which is 1.5% of the company's total share capital, from May 27 to August 26, 2025 [1] Group 2 - Shareholders of Chuhuan Technology plan to reduce their holdings by up to 2,395,605 shares, accounting for 3% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [1] - Major shareholder of Dalian Technology intends to reduce their holdings by up to 4,189,336 shares, which is 0.99% of the company's total share capital from May 27 to August 26, 2025 [2] - Dongwei Technology's board members plan to reduce their holdings by a total of 2,574,857 shares, representing 0.8629% of the company's total share capital during the same period [2] Group 3 - Gann Li Pharmaceutical's shareholder has completed a reduction of 6,010,622 shares, which is 1% of the company's total share capital from April 22 to April 30, 2025 [2] - Guanshi Technology's board members plan to reduce their holdings by up to 359,375 shares, accounting for 0.4891% of the company's total share capital from May 27 to August 26, 2025 [2] - Guoguang Electric's shareholder has completed a reduction of 1,625,751 shares, which is 1.5% of the company's total share capital from April 25 to April 30, 2025 [2] Group 4 - Haili Biological's major shareholder has completed a reduction of 13,113,244 shares, representing 2% of the company's total share capital from April 15 to April 22, 2025 [3] - Hengfeng Information's board member has completed a reduction of 198,717 shares, which is 0.1207% of the company's total share capital on April 28, 2025 [3] - Hongwei Technology's shareholder plans to reduce their holdings by up to 820,000 shares, accounting for 0.39% of the company's total share capital from May 12 to August 11, 2025 [3] Group 5 - Huatai Medical's vice president has completed a reduction of 29,943 shares, which is 0.0308% of the company's total share capital from April 28 to April 29, 2025 [4] - Jilin Carbon Valley's major shareholder has completed a reduction of 4,989,160 shares, representing 0.8490% of the company's total share capital from April 25 to April 29, 2025 [4] - Jiahua Technology's shareholder plans to reduce their holdings by up to 1,160,000 shares, accounting for 1.50% of the company's total share capital from May 28 to August 25, 2025 [4] Group 6 - Jiangbo Long's shareholder plans to reduce their holdings by up to 4,159,815 shares, which is 1% of the company's total share capital from May 27 to August 26, 2025 [5] - Jiangshan Co. plans to reduce its holdings in Jiangtian Chemical by 4,330,800 shares, accounting for 3% of its total share capital from May 27 to August 26, 2025 [5] - Kairun Co.'s major shareholder plans to reduce their holdings by up to 9,000,000 shares, representing 2.43% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [5] Group 7 - Lianqi Technology's shareholders plan to reduce their holdings by a total of 18,717,374 shares, which is 2.96% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [9] - Zhongke Information's board members have completed a reduction of 698,914 shares, representing 0.2358% of the company's total share capital [9] - Zhongshi Co.'s major shareholder plans to reduce their holdings by up to 1,800,000 shares, accounting for 1.1527% of the company's total share capital from May 27 to August 26, 2025 [10]

欣天科技(300615.SZ)公告称，持股9.15%的股东薛枫因个人资金需要，计划在未来3个月内，以集中竞 价或大宗交易方式合计减持公司股份不超过5,804,076股，占公司总股本的3%。减持期间为2025年5月27 日至8月26日。 ...

持本公司股份 17,702,112 股（占本公司总股本比例 9.15%）的持股 5%以上股 东薛枫先生因个人资金需要，计划在本次减持计划预披露公告之日起 15 个交易 日后 3 个月内，以集中竞价或大宗交易方式合计减持公司股份不超过 5,804,076 股 （占公司总股本的比例约为 3%）。 深圳市欣天科技股份有限公司（以下简称"公司"或"欣天科技"）收到持股 5%以上股东薛枫先生出具的《关于股份减持计划的告知函》，现将有关情况公告 如下： 证券代码：300615 证券简称：欣天科技 公告编号：2025-038 深圳市欣天科技股份有限公司 关于持股 5%以上股东减持股份的预披露公告 公司持股 5%以上股东薛枫先生保证向本公司提供的信息内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 一、股东基本情况 | 股东 | 持有公司股份数量（股） | 占公司总股本的比例 | | --- | --- | --- | | 薛枫 | 17,702,112 | 9.15% | 二、本次减持计划的主要内容 1、减持原因：个人资金需要 2、 ...

Core Viewpoint - Xintian Technology (欣天科技) reported a significant decline in its 2024 annual performance, with total revenue dropping to 277 million yuan, a year-on-year decrease of 55.02%, and a net profit loss of 18 million yuan, reflecting a staggering year-on-year decline of 130.38% [1][4]. Group 1: Performance Overview - The company's total revenue for 2024 was 277 million yuan, down 55.02% year-on-year [1]. - The net profit attributable to shareholders was -18 million yuan, a year-on-year drop of 130.38% [1]. - The non-recurring net profit was -23.17 million yuan, representing a 143.12% decline year-on-year [1]. Group 2: Market Conditions - The slowdown in global 5G network construction, particularly in Europe and the United States, has adversely affected the company's communication business [4]. - Sales volume of communication products decreased by 54.28% year-on-year, with main business revenue declining by 55.85% [4]. - The stagnation of projects in the Indian market significantly impacted the company's performance, as previous infrastructure expansion had driven growth [4]. Group 3: Emerging Business Challenges - Although there was growth in the product lines related to new energy and medical devices, these businesses have not yet achieved scale effects, contributing minimally to overall performance [5]. - Production capacity for new energy and medical components remained stable compared to the previous year, but sales and revenue did not meet expectations [5]. - The potential for new energy and medical products to become new growth points remains uncertain and requires time for market expansion [5]. Group 4: Cost and Profitability Issues - The company faced increased cost control pressures due to rising raw material prices, leading to higher operating costs and reduced profit margins [6]. - The comprehensive gross margin decreased by 7.35% year-on-year, reaching 21.68% [6]. - Period expenses increased, with sales expenses rising by 102.63 thousand yuan and management expenses increasing by 225.45 thousand yuan, primarily due to higher depreciation and amortization costs [6].

证券代码：300615 证券简称：欣天科技 公告编号：2025-029 深圳市欣天科技股份有限公司 关于预计公司 2025 年度日常关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、 日常关联交易的基本情况 （一）关联交易概述 深圳市欣天科技股份有限公司（以下简称"公司"）及其合并范围内下属子公 司根据日常经营需要，预计在 2025 年度将与公司关联方东莞鸿爱斯通信科技有 限公司（以下简称"东莞鸿爱斯"）、南京晶萃光学科技有限公司（以下简称"晶 萃光学"）发生日常经营性关联交易，交易金额合计不超过 3,600 万元。 2025 年 4 月 18 日，公司召开了第五届董事会第二次会议及第四届监事会第 二十二次会议，审议通过了《关于预计 2025 年度日常关联交易的议案》，关联董 事孙海龙先生已回避表决。本次关联交易事项在提交董事会审议前已经公司第四 届董事会独立董事专门会议 2025 年第一次会议审议和第四届审计委员会 2025 年 第一次会议审议，并经全体独立董事过半数同意。 根据《深圳证券交易所创业板股票上市规则（2024 年修订）》和《公 ...

深圳市欣天科技股份有限公司 2024 年度财务决算报告 深圳市欣天科技股份有限公司（以下简称"公司"）2024年12月31日的合并及母 公司资产负债表、2024年度的合并及母公司利润表、合并及母公司现金流量表、合 并及母公司所有者权益变动表，以及财务报表附注经立信会计师事务所（特殊普通 合伙）审计，并出具了信会师报字[2025]第ZI10231号标准无保留意见的审计报告。 现就公司2024年度财务决算情况报告如下： | | | | 单位：万元 | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | 增减比例 | | 营业收入 | 27,715.06 | 61,613.26 | -55.02% | | 利润总额 | -1,900.26 | 8,812.63 | -121.56% | | 归属于母公司股东的净利润 | -1,833.27 | 6,033.76 | -130.38% | | 每股收益（元/股） | -0.10 | 0.32 | -131.25% | | 加权平均净资产收益率 | -3.44% | 10.93% | -14.37% | | 项目 | 本报告期末 ...

深圳市欣天科技股份有限公司 董事会审计委员会关于对会计师事务所 2024 年度履职 情况评估及履行监督职责情况的报告 深圳市欣天科技股份有限公司（ 以下简称"公司"）董事会审计委员会根据（ 中 华人民共和国公司法》 中华人民共和国证券法》 上市公司治理准则》 国有企 业、上市公司选聘会计师事务所管理办法》 深圳证券交易所上市公司自律监管 指引第 2 号——创业板上市公司规范运作》等法律法规、规范性文件以及（ 公司 章程》 董事会审计委员会工作细则》等规定和要求，本着勤勉尽责的原则，恪 尽职守，认真履职。现将董事会审计委员会对会计师事务所 2024 年度履职评估 及履行监督职责的情况汇报如下： 截至 2024 年末，立信拥有合伙人 296 名、注册会计师 2,498 名、从业人员 总数 10,021 名，签署过证券服务业务审计报告的注册会计师 743 名。 立信 2024 年业务收入（ 未经审计）50.01 亿元，其中审计业务收入 35.16 亿 元，证券业务收入 17.65 亿元。 2024 年度立信为 693 家上市公司提供年报审计服务，审计收费 8.54 亿元， 与公司同行业上市公司审计客户 93 家。 ...

证券代码：300615 证券简称：欣天科技 公告编号：2025-028 为保证授信融资方案的顺利实施，公司及子公司拟为全资子公司苏州欣天新 精密机械有限公司（以下简称"苏州欣天新"）、全资孙公司苏州欣天盛科技有限 公司（以下简称"苏州欣天盛"）、控股子公司东莞艾斯通信科技有限公司（以下 简称"艾斯通信"）、控股孙公司东莞市索思智联通信有限公司（以下简称"索思 智联"），参股公司东莞鸿爱斯通信科技有限公司（以下简称"东莞鸿爱斯"），提 供合计不超过人民币 3.20 亿元的连带责任保证。 根据《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自 律监管指引第 2 号——创业板上市公司规范运作》《公司章程》等规定，上述事 深圳市欣天科技股份有限公司 关于公司及子公司 2025 年度银行综合授信暨关联担保额度 预计的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示：深圳市欣天科技股份有限公司（以下简称"公司"）本次预计的 2025 年度公司及子公司担保额度为合计不超过人民币 3.20 亿元，占公司最近一 期经审计净资产的 60.70%，本次担保 ...

深圳市欣天科技股份有限公司 2024 年度董事会工作报告 2024 年，深圳市欣天科技股份有限公司（以下简称"公司"）董事会严格按 照《中华人民共和国公司法》、《中华人民共和国证券法》等法律法规和《公司章 程》等相关规定，切实履行董事会职能，认真贯彻执行股东大会通过的各项决议， 及时履行信息披露义务，有效地保障公司和全体股东的利益，保证了公司持续、 健康、稳定的发展。现将董事会 2024 年度的主要工作情况报告如下： 一、报告期内公司主要经营情况 2024 年，公司实现营业收入 27,715.06 万元，较上年同期下降 55.02%；总资 产 65,515.79 万元，较上年同期下降 6.14%；归属于母公司的所有者权益合计 52,719.27 万元，较上年同期下降 2.44%；归属于母公司股东的净利润-1,833.27 万元，较上年同期下降 130.38%。 二、报告期内董事会日常工作情况 公司董事会下设四个专门委员会：战略委员会、审计委员会、提名委员会、 薪酬和考核委员会。报告期内，各专门委员会按照《公司章程》《董事会议事规 则》及各专门委员会的实施细则等相关规定认真履行各项职责，为董事会在不断 完善公司 ...